Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma (TACE)

This study has been completed.
Information provided by (Responsible Party):
ShenFeng, Eastern Hepatobiliary Surgery Hospital Identifier:
First received: January 8, 2009
Last updated: August 10, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)